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ABSTRACT
Autism spectrum disorder (ASD) is a neurological disorder characterized by decreased
sociability, deficits in communication, and restricted and repetitive behaviors. The
ketogenic diet (KD), a high-fat, low-carbohydrate, and moderate-protein diet has been
shown to improve these three behavioral symptoms in the BTBR mouse model of autism.
However, further research is required to strengthen the body of knowledge surrounding
the potential of KD as diet therapy for autism. Epidemiological observations have shown
that maternal immune activation (MIA) during pregnancy increases the risk of autism in
offspring. Based on these observations, the polyinosinic:polycytidylic acid (poly(IC)) mouse
model was developed as an animal model to study autism. Poly(IC) is a synthetic analog of
double stranded RNA and acts as a viral mimic. It is injected into a pregnant dam, activating
an immune response without causing an infection. The offspring of this protocol are the
poly(IC) MIA mouse model. They have been shown to have the autistic symptoms of deficits
in sociability and communication as well as increased repetitive behaviors. In this study,
pregnant dams were injected with poly(IC) or the saline vehicle during the late first
trimester. The offspring were separated into control and test groups. At 5 weeks of age, the
test group was placed on a 6:1 fat:(carbohydrates + protein) KD while the control groups
remained on standard chow. After three weeks on the diet, we assessed sociability,
repetitive behavior, and communication. Our results showed that KD reversed increased
self-grooming in poly(IC) mice. Results did not indicate autistic-like behavior in our
poly(IC) mice for social contact, sociability, grooming during the 3-chamber test, or
repetitive behavior in the marble-burying test. However, KD increased social contact in
poly(IC) mice. It also increased sociability and decreased 3-chamber grooming in poly(IC)
males. Poly(IC) mice did not have a deficit in the social transmission of food preference
task, a previously unused assessment of the poly(IC) mouse model. While our study did not
succeed in replicating several autistic behaviors in the poly(IC) mouse model, KD had
influence on behavior in multiple measures, increasing sociability and decreasing
grooming. This suggests that KD may be an effective diet therapy for autism.
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INTRODUCTION
AUTISM SPECTRUM DISORDER DEFINITION & DIAGNOSIS
Autism

spectrum

disorders

(ASD)

are

a

heterogeneous

group

of

neurodevelopmental disorders characterized by deficits in social communication and
interaction as well as repetitive and restricted behaviors. While instances of ASD are often
referred to simply as autism, these disorders incorporate a wide range of symptoms which
additionally can range from mild to severe. ASD includes multiple disorders such as autism,
Asperger syndrome, childhood disintegrative disorder, and pervasive developmental
disorders-not otherwise specified (PDD-NOS) (Kim & Lord, 2013).
Diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders
(DSM V) of the American Psychiatric Association (APA) currently include the presentation
of social communication and interaction impairments and repetitive and restricted
behaviors in early development. Diagnosis generally occurs on average around 4 years of
age and is still entirely behaviorally based as there are currently no reliable biological
markers for autism (Kim & Lord, 2013). Later in life, these symptoms cause significant
impairment in the social or occupational life of the patient (APA, 2013). Other symptoms
can include intellectual, language, sensory, and motor impairments (Kim & Lord, 2013).

IMPACT & PREVALENCE OF ASD
ASD can severely compromise the quality of life in children and adults with the
disorder. Their behaviors—which can include complex rituals, tantrums, and even selfinjury—can be highly disruptive to daily life. The detriment to relationships, school, and
employment can have lasting effects on the life trajectory of autistic individuals. Patients
often do not achieve full independence (Lee et al., 2008). Medical expenditures for autistic
6

children are significantly higher than they are for their healthy peers. The lifetime cost of
autism was estimated in 2007 to be $3.2 million (Ganz, 2007). In the UK, the public cost of
supporting children was estimated in 2009 to be £2.7 billion annually and, for adults, £25
billion (Knapp et al., 2009).
The Centers for Disease Control and Prevention reported that the overall prevalence
of ASD in 2010 was estimated to be about 1 in 68 among 8 year olds in the United States.
This has increased from a rate of 1 in 110 in 2006. In the past 40 to 50 years it has been
estimated that rates of autism have increased by at least a factor of 20. The ratio of ASD
diagnosis differs significantly between the sexes at a ratio of approximately 4.5 males to 1
female. The factors leading to the increase in rates of autism are unclear and likely
multifactorial, including greater capabilities of detection, heightened awareness, and an
increase in risk factors or etiology (CDC, 2014; Currenti, 2010). Interestingly, 3-25% of
individuals eventually lose their ASD diagnosis. Different types of ASD or inaccurate
diagnosis could explain these findings. Additionally, effective treatment may maximize the
likelihood of children achieving this optimal outcome (Helt et al., 2008; Fein et al., 2013).

TREATMENT OF ASD
Unfortunately, there is no cure for ASD and the treatments for the disorders are
limited. The most effective treatment options for ASD include the combination of
educational programming and behavioral intervention. In this treatment, patients undergo
training for speech, language, social skills, and behavior. Ideally such therapy and education
begins as early as possible. Such treatment requires frequent intensive sessions with
trained professionals, making it very expensive and time-consuming. Additional treatment
options include addressing the non-core symptoms of ASD such as motor therapy for motor
7

deficits and risperidone or aripiprazole for irritability, as well as medications for
inattention, hyperactivity, sleep problems, anxiety, mood, and aggression (Lofthouse et al.,
2012). Treating comorbidities such as seizures, gastrointestinal, metabolic, and hormonal
disorders can also help a patient (Bauman, 2014). However, medications for these
symptoms are often less effective for children with ASD than they are for those without and
they often come with serious side effects. Other complementary and alternative treatments
include diet intervention, meditation, therapy animals, chelation therapy and music
therapy. But many of these treatments are still unsubstantiated (Lofthouse et al., 2012;
Matson et al., 2013).

NEUROANATOMY & ETIOLOGY OF ASD
There are currently no consistent neuroanatomical pathologies confirmed for ASD.
However, the characteristic symptoms of ASD suggest involvement of the frontal lobe,
superior temporal cortex, the parietal cortex, amygdala, orbitofrontal cortex, caudate
nucleus, and language cortices (Amaral et al., 2008). Various structures have been
implicated in postmortem and structural magnetic resonance imaging. Differences have
been seen in the volume of the total brain, cerebral hemispheres, cerebellum, caudate
nucleus, corpus callosum, and amygdala (Amaral et al., 2008; Stanfield et al., 2008). Overall,
the brain of a child with ASD is enlarged relative to controls during early postnatal life and
then growth decreases relative to controls in adolescence. Studies have suggested that the
abnormal enlargement of the amygdala is correlated with heightened anxiety. However,
these studies have been limited due to factors such as small sample size, comorbidities, and
the inability to confirm diagnosis until 2-3 years of age (Amaral et al., 2008; Stanfield et al.,
2008).
8

The cause of autism is still largely unknown and no reliable biomarkers have been
identified. ASD is likely a disorder resulting from a combination of genetic and
environmental factors. ASD can be caused by known genetic syndromes, and this is the case
for approximately 15% of instances of ASD and typically known as syndromic autism
(Gabrucker, 2013). Fragile X syndrome, tuberous sclerosis, neurofibromatosis, untreated
phenylketonuria, Angelman, Cornelia de Lange, and Down syndrome can all present
autistic features. The most common of these are Fragile X syndrome and tuberous sclerosis
which both increase protein synthesis (Laumonnier et al., 2004; Persico & Napolioni,
2013). Autism is strongly associated with mutations in genes which encode for proteins
that play a role in regulating synaptic protein synthesis (Persico & Napolioni, 2013).
Indeed, a cross-sectional study of 210 dizygotic twins and 67 monozygotic twins
under the age of 18 revealed that rates of ASD concordance between dizygotic and
monozygotic twins are 31% and 88%, respectively. The 4:1 male to female ratio of
incidence suggests there is a sex-linked genetic influence. The possession of two X
chromosomes may provide protection for females. Interestingly, all 9 pairs of female
monozygotic twins in the study had a concordance of 100% while the 113 dizygotic twin
pairs containing at least one female had a concordance of only 20% (Rosenberg et al.,
2009). Maternal environment during pregnancy is also considered a factor due to a higher
concordance rate between dizygotic twins than between siblings (3-14%) (Sumi et al.,
2006). A study by Schwartzer et al. found that in mouse models of autism, prenatal
exposure to maternal immune activation in genetic mouse models of autism exacerbated
their autistic symptoms, further suggesting an interaction between genetic and
environmental factors in the etiology of autism (2013).
9

MATERNAL ENVIRONMENT
Maternal environment is associated with a number of developmental neurological
disabilities and disorders. Approximately 1 in 33 U.S. children are born with a birth defect.
Only about 25% of these congenital abnormalities can be attributed to solely genetic
causes. It is estimated that about 15% of developmental disorders are the result of
environmental factors alone. The remaining 60% of disorders are multifactorial
combinations of genetic and environmental causes or have currently unknown origins
(Czeizel, 2005).
In the case of ASD, there are a number of associated maternal environment risk
factors. Abnormalities in fetal growth, whether above or below standard are associated
with greater ASD risk (Abel, 2013). Furthermore, risk of ASD was decreased by
approximately 40% in mothers who took prenatal supplements at least 4 times per week
during the preconceptional window (3 – 1 months before conception) (Schmidt et al.,
2011). Taking valproic acid, an antiepileptic, during the prenatal period has been shown to
increase risk of ASD behaviors in humans and animal models. (Engel & Daniels, 2011;
Ornoy, 2009; Dean et al., 2002). Zinc deficiency, maternal diabetes, toxins, parental age,
prenatal and perinatal stress, and prenatal infection are all events and situations currently
recognized as environmental risk factors for ASD (Grabrucker, 2013).

MATERNAL IMMUNE ACTIVATION AND ASD
Maternal infection has been associated with risks of various neurodevelopmental
disorders, such as schizophrenia, autism, and cerebral palsy (Boksa, 2010). Evidence for
the significance of prenatal infection on the risk of ASD is strong and growing. Prenatal
viral infection exposure in the first trimester and bacterial infection in the second trimester
10

correlate with increased risk of ASD diagnosis in offspring (Atladottir et al., 2010). This
effect has also been seen in animal models including mice, rats, and non-human primates
(Boska, 2010; Bauman, 2014). Mothers with autistic children are more likely to have
autoantibodies with negative effects on fetal brain development. It is suggested that these
are transferred through the placenta to the offspring (Currenti, 2010). Mothers of autistic
children are also more likely to have autoimmune diseases such as rheumatoid arthritis,
celiac disease, and type 1 diabetes (Patterson, 2011).
The mechanisms by which maternal immune activation (MIA) increases the risk of
ASD is not fully understood, but it is likely multifactorial. Data suggests that this
environmental factor combines with genetic risk factors. Indeed, there is an association
between being born at the peak of the influenza season and having tuberous sclerosis with
autistic behaviors (TSC-ASD) while there is no such association between date of birth and
TSC alone (Patterson, 2011). The multiple neurobiological effects MIA has on animal
models may help to explain its mechanisms of action. MIA has been shown to increase
circulating interleukin-6 (IL6) and placental cytokines. It is known to lead to oxidative
stress, morphological changes in the brain, and changes in neurotransmitter systems
(Boksa, 2010; Patterson, 2011).

IMMUNE DYSFUNCTION & INFLAMMATION
The influence of MIA is likely connected to the data showing immune dysfunction
and inflammation in individuals with ASD. The association between ASD and immune
dysfunction and inflammation is the most strongly supported correlations between ASD
and a physiological abnormality (Rossignol & Frye, 2012). This relationship is shown in
many ways. The immune system of autistic individuals is often abnormal. Families with
11

autism are more likely to have autoimmune disorders (Croen et al., 2005). Autistic children
show serum antibody reactivity against human cortical and cerebellar brain regions
(Currenti, 2010). An inflammatory-like state was found in postmortem autism brains: there
were elevated cytokines and activated microglia and astrocytes throughout subjects
ranging in age from 5 to 44 years, indicating that these changes occur early and are likely
permanent (Vargas et al., 2005). Similarly, raised cytokines were also found in the
cerebrospinal fluid of living autistic children (Chez et al., 2007). Additionally, autistic
subjects have elevated plasma cytokines and chemokines; the blood brain barrier is
permeable to these pro-inflammatory mediators (Ashwood, et al., 2011; Li et al., 2009).
Inflammation in the gastrointestinal tract has also been indicated, perhaps contributing to
the comorbidity between autism and gastrointestinal problems. Furthermore, microarray
studies of autistic brains have shown that there is dysregulation of genes relating to
immune function (Patterson, 2011).
The interaction between immune dysfunction/inflammation and ASD is not fully
understood. Genetic susceptibility to immune-related disorders could alter brain function.
However, altered brain morphology could also interfere with immune function, making this
dysregulation a symptom rather than a cause. Some genes considered in the etiology of
autism regulate both brain and immune development. Such genes include macrophage
migration inhibitory factor (MIF), MET encoding tyrosine kinase, the reelin gene (RELN)
and the human leukocyte antigen (HLA) genes (Careaga et al., 2012).
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POLY(IC) MOUSE MODEL
In order to further investigate MIA as a risk for autism, research has developed MIA
animal models of autism. Many animal modeling studies have shown that acute and lasting
changes to behavior and CNS structure and function can be caused by prenatal immune
activation. These studies, however, have varied regarding the materials, species, methods,
and measurements used (Boksa, 2010). Both rodent and non-human primate models have
exhibited abnormal, ASD-like behavior as a result of MIA (Boska, 2010; Bauman, 2014).
Agents used for creating prenatal immune activation can cause an antiviral response, such
as in the case of polyinosinic:polycytidylic acid (poly(IC)), or they can cause an
antibacterial response, such as in the case of lipopolysaccharide (LPS) (Patterson, 2011).
This thesis investigated the effectiveness of dietary treatment for ASD using the
poly(IC) mouse model. Offspring of dams injected with poly(IC) have been found to exhibit
the core deficits of autism: decreased social and communicative behavior as well as
increased repetitive and stereotyped behavior (Malkova et al., 2012). The mechanism by
which poly(IC) has this effect has been explored. Poly(IC) mimics the structure of dsRNA
that results from viral replication. It binds to the Toll-like receptors, dsRNA-activated
protein kinase, and other proteins, activating an immune response and a cellular danger
response. Poly(IC) inhibits translation of cap-dependent mRNAs and stimulates IL1β, IL6,
TNFα, type I interferons (IFN) alpha and beta. Exposure to poly(IC) produces an observable
response of initial fever followed by hypothermia as well as weight loss and reduced
activity, food intake, and water intake. Recovery occurs approximately 24 hours after
exposure (Naviaux et al., 2013; Traynor et al., 2004).
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In addition to increasing cytokines and chemokines, poly(IC) also leads to deficits in
the mitochondrial function of leucocytes. Adult offspring had significant decreases in
mitochondrial ATP production (Arrode-Bruses & Bruses, 2012; Giulivi, 2013). This
significant difference in metabolic function suggests that diet therapy may be an effective
treatment for the poly(IC) model of ASD.

KETOGENIC DIET AND ASD
The ketogenic diet (KD) is a restricted carbohydrate, sufficient protein, and high fat
metabolic therapy. KD has been used effectively as a diet therapy for epilepsy since the
1920s, with an average of 43% of children and adults reaching greater than or equal to a
50% seizure reduction (Payne, 2011). It has been shown to have various beneficial effects
for many neurological diseases, including headache, neurotrauma, Alzheimer's disease,
Parkinson's disease, sleep disorders, brain cancer, pain, multiple sclerosis, and depression
(Stafstrom & Rho, 2012). ASD and epilepsy are highly comorbid, and it is suggested that KD
may be an effective therapy for ASD symptoms (Kim & Lord, 2013; Ruskin et al., 2013).
Indeed, therapeutic effects of KD have been shown for autism (Ruskin et al., 2013). A
BTBR mouse model, which exhibits impaired sociability and communication as well as
increased repetitive and restricted behaviors, was fed a strict KD (6.6:1 fats:(carbohydrates
+ proteins)). The diet alleviated all three of the core behavioral deficits (Ruskin et al.,
2013).The mechanisms by which KD has neuroprotective and therapeutic effects are not
yet fully understood, but there are several properties of the diet that may provide
explanation for its potential use with ASD.
KD has anti-inflammatory properties which may relieve inflammation and
inflammation-related symptoms in ASD (Yang & Chenge, 2010; Kim et al., 2007; Gasior,
14

2006; Cullingford, 2004). It also reduces thermal nociception in juvenile and adult rats
(Ruskin et al., 2009). A suggested mechanism for this anti-inflammatory effect is that
saturated fatty acids, the predominant energy fuel for a body on the ketogenic diet,
contribute to the regulation of inflammatory response genes by activating toll-like
receptors that activate nuclear factor-kappa B and cycloocygenase-2 (Forsythe et al., 2008).
In a study examining a murine model of experimental autoimmune encephalomyelitis, KD
decreased inflammatory cytokines and chemokines while also improving motor disability,
spatial learning and memory, and long-term potentiation in the CA1 hippocampus region
(Hao et al., 2012).
The influence of the ketogenic diet on metabolism is also likely key for the beneficial
effects of the diet. Metabolic disorders are common in autism. Mitochondrial electron
transport chain complexes have decreased expression in the cerebellum and frontal and
temporal regions in children with autism, likely contributing to abnormal metabolism and
oxidative stress (Chauan et al., 2011). KD switches the body's energy source from glucose
to ketones, fundamentally altering metabolism.
One suggested metabolic mechanism by which the ketogenic diet may be effective is
through adenosine. Adenosine is a neuromodulatory purine that acts as a sleep modulator
and anticonvulsant and is a core component of ATP (Masino et al., 2011). Additionally,
adenosine kinase inhibitor and adenosine deaminase inhibitor have antinociceptive and
anti-inflammatory effects (Poon & Sawynok, 1999). Those with ASD, as previously
mentioned, often suffer from comorbidities of sleep disorders and epilepsy and ASD is
highly associated with inflammation (Masino et al., 2011). Variants of adenosine A2A
receptor gene have been associated with increases in autistic symptoms (Freitag et al.,
15

2009). Additionally, autistic children have been reported to have reduced adenosine
deaminase activity (Bottini et al., 2001). KD has been shown to increase ATP and adenosine
in the brain (Nakazawa et al., 1983; Masino et al., 2009). Ketone bodies are increased while
on the ketogenic diet. These ketone bodies substitute for glucose and are more efficient in
ATP production (Masino et al., 2009).
The present study will investigate the ability of the ketogenic diet to alleviate the
autistic symptoms in the poly(IC) mouse model of ASD, further illuminating the therapeutic
relevance of KD for ASD.
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THESIS OVERVIEW
The current study aims to investigate the effect of the ketogenic diet on the poly(IC) mouse
model of autism in order to further the body of knowledge regarding the applications and
efficacy of ketogenic diet therapy. Beneficial effects of the ketogenic diet were found
previously in the BTBR strain of mice which, however, have an undefined genetic etiology
of autism; therefore we chose to use this environmental model. It is hypothesized that the
ketogenic diet will relieve autistic behaviors within the poly(IC) mouse model.
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MATERIALS AND METHODS
ETHICS STATEMENT
All procedures were performed in accordance with the NIH Guide for the Care and
Use of Laboratory Animals, and approved by the Animal Care and Use Committee of Trinity
College (A3869-01).

ANIMALS
Adult female C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) were
determined to be "proven breeders" after having one or more previously successful litters.
These breeders were housed socially with same-sex cage mates. Estrous cycle was visually
monitored daily for each mouse. When a breeder was determined to be in proestrus/estrus
phase, she was housed overnight with an adult male C57Bl/6 mouse. The following
morning, the female mouse was checked for the presence of a vaginal plug, which marked
embryonic day 0.5 (E0.5). Pregnant females were housed socially and not disturbed except
for weekly cage cleaning.
On day E10.5, dams were weighed and assigned to either the poly(IC) or saline
injection group. Injections of 5mg/kg poly(IC) (potassium salt; P9582; Sigma, St. Louis, MO)
or saline were administered intraperitoneally on days E10.5, E12.5, and E14.5. Poly(IC)
was supplied by the manufacturer at 10% of the total weight of the salt, and the dosage was
based on the weight of poly(IC) itself. All pups from each litter remained with the mother
postnatal day 21 (P21), at which time they were weaned and housed socially with same-sex
littermates. In the case of only one male or female pup in a litter, the pup was house socially
with same-sex, same-age untreated C57 pups.
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Between P21 and 5 weeks of age, all offspring were fed control diet (CD; LabDiet
5001, W.F. Fisher & Son, Somerville, NJ). At 5 weeks of age, poly(IC) mice were separated
into control and test groups and were either kept on CD or switched to KD (F3666; BioServ,
Frenchtown, NJ), respectively. Mice of the saline-treatment group were kept on CD. A
saline-treatment group on KD was not included because previous testing has shown KD has
no significant effect on behavior in C57Bl/6 control mice (Ruskin et al., 2013). All testing
occurred at 8-10 weeks of age at 3-5 weeks of dietary treatment.

BEHAVIORAL TESTING
SOCIABILITY
Sociability was testing using the three-chamber sociability test. A 22 x 42.5 x 19 cm
Plexiglas box divided into three equal chambers was used. A 6 x 6 cm door in each of the
internal walls allowed for free movement between the chambers. A small cylindrical wire
cage (diameter 10.4 cm, height 11 cm, bar intervals 1 cm) was placed in both side
chambers. Test subject mice were first habituated to the testing room for 30 minutes and
then habituated to the central chamber for 10 minutes with the doors closed. Testing
occurred in three 10 minute phases in which the test mouse was allowed to roam freely
between chambers (Fig. 1). The test mouse was placed in the central chamber and the
doors were lifted at the start of the phase. In the first phase, both wire cages were empty,
allowing for a test of side bias. In phase two, a "stranger" mouse (C57Bl/6) was placed in
the wire cage of one side chamber, allowing for a test of sociability. In the third phase a
novel "stranger" mouse was placed in the other wire cage to allow for a test of preference
for social novelty. The placement of the initial stranger mouse was counterbalanced
between tests. Stranger mice were sex- and diet-matched to the test mouse, having started
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the matched diet several days before testing to account for diet-related olfactory cues. In
each phase, mice activity was video recorded and scored for time spent in each chamber
and social contact (nose/face/forepaw contact with the cages and/or the stranger mice).

Tests for side bias

Tests for sociability
preference

Tests for social novelty
preference

Figure 1. Three-Chamber Test Paradigm.
REPETITIVE & COMPULSIVE BEHAVIOR
Self-grooming was quantified in the three-chamber sociability testing and during a
separate 10 minute test in order to measure self-directed repetitive behavior. In this test,
the mouse was habituated to the room for 30 minutes and then habituated to the
experimental polypropylene cage (19 x 29 x 12.5 cm) for 10 minutes. Mouse behavior was
video recorded and quantified in a 10 minute phase following habituation.
Compulsive behavior was measured using the marble-burying test. Mice were
allowed to habituate to the room for 30 minutes. An experimental polypropylene cage (19 x
29 x 12.5 cm) was prepared with leveled 5 cm deep clean wood chip bedding (Betachip,
Charles River). 15 black glass marbles (1.5 cm diameter) were evenly spaced in a 5 x 3 grid
on top of the bedding. After habituation, the test mouse was placed in the experimental
cage. After 30 minutes, the mouse was removed and returned to its home cage. A digital
picture of the experimental cage was taken from above. Photoshop was used to count
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marble pixels, using the "quick selection" tool, and to measure the bedding area, using the
"polygonal lasso" tool. Marble pixels were expressed as a percent of the total bedding area
pixels. A lower percentage of marble pixels is interpreted as indicating more burying and
thus greater compulsive behavior.
SOCIAL COMMUNICATION
Social communication was measured using the social transmission of food
preference (STFP) test. Mice were habituated to eating KD or powdered CD, as appropriate,
from clear glass jars (Dyets, Inc., Bethlehem, PA) 24 hours prior to the beginning of testing.
The round jars had perforated lids, allowing for access to food and diminishing the
displacement of food from mice digging. To begin the testing, a demonstrator mouse was
removed from the home cage and placed in solitary housing. Both the demonstrator mouse
and cage mates then fasted for 18 hours. A feeding jar containing a weighed amount of
flavored powdered control diet food ("trained" flavor; 1% cinnamon or 2% cocoa) was
presented to the demonstrator mouse and remained in the cage for 2 hours. If the
demonstrator mouse had not yet eaten >0.5g of food, the diet was returned to the
demonstrator. Once the demonstrator consumed >0.5g of food, it was returned to the home
cage and allowed to interact with the cage-mate observer mice for 30 minutes. Observer
mice were then separated into individual cages with a jar of the "trained" flavor and a jar of
the "untrained" novel flavor. Jars were weighed before and after a 2 hour period in order to
determine the preferred flavor.
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Figure 2. Social Transmission of Food Preference Test Paradigm.

BLOOD ANALYSIS
After the marble-burying
burying test, blood glucose, ketone (beta
(beta-hydroxybutyrate,
hydroxybutyrate, or BB
HB) levels were measures. Placed briefly in a plastic container with isoflurane vapors
(Animal Health International), mice were anesthetized. Once unconscious, the mouse was
removed and the tail vein was punctured with a razor blade. Blood was then analyzed for
glucose and ketones using Precision Xtra meters (Abbott Laboratories, Bedford, MA). Mice
were returned to their home cage to awake from anesthesia.

STATISTICAL ANALYSIS
Social and grooming behavior videos were scored by two independent researchers,
at least one of whom was blind to treatment. Sociabili
Sociability
ty preference in the three-chamber
three
sociability test was defined as the ratio of time spent in the "social" chamber to the total
time spent in side chambers. Statistical analysis was conducting using student t-tests
t
or
ANOVA with Newman-Keuls
Keuls post
post-hoc tests to determine diet, treatment, sex, and
interaction effects. When sex differences were not found, data was collapsed across male
and female mice. Outliers in each group during a given test were identified using Grubb’s
outlier test and excluded from analys
analysis. Data are reported as mean +- standard error. P
<0.05 was considered significant.
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RESULTS
Following 3-5 weeks on their respective diets, the saline-CD, poly(IC)-CD, and
poly(IC)-KD groups underwent blood, weight, and behavioral testing in order to investigate
the influence of KD on the autistic behaviors of the poly(IC) mouse model.

BLOOD ANALYSIS
Tail blood was collected under anesthesia to measure blood ketones and glucose
levels. Poly(IC) mice fed KD had significant blood chemistry changes. For both male and
female mice, ketone levels were significantly higher for the KD group compared to the CD
groups (Fig. 3A). Within the poly(IC) groups, female mice had significantly higher ketone
levels than their male counterparts (Fig. 3A). Mice fed KD also had significantly decreased
glucose levels (Fig. 1B). There were no significant glucose differences between sexes.

2.5

A

Blood Ketone Levels
180

###

140

***
1.5

1.0

Blood Glucose Levels

160

***

#

Glucose (mg/dL)

Ketones (mM)

2.0

Males
Females

B

***

120
100
80
60
40

0.5

20
0.0

0
saline-CD

poly(IC)-CD

poly(IC)-KD

saline-CD

poly(IC)-CD

poly(IC)-KD

Treatment
Treatment
Figure 3. KD increases ketone levels and decreases glucose levels in poly(IC) mice. (A) shows ketone
levels (mM) for both sexes in each treatment-diet condition. Levels were significantly higher for male and
female poly(IC)-KD mice than male and female CD groups. Females in the poly(IC)-KD and poly(IC)-CD groups
had significantly higher ketone levels than the males of their treatment-diet group. (saline-CD: male n=7,
female n=15; poly(IC)-CD: male n=8, female n=12; poly(IC)-KD: male n=10, female n=11; *** p<0.001
between groups, ### p<0.001 within group, # p<0.05) There was no significant condition x sex interaction.
(B) shows glucose levels (mg/dL) in each treatment-diet condition. There were no significant sex differences,
so data was collapsed. The poly(IC)-KD group had significantly lower glucose that the poly(IC)-CD and salineCD groups. (saline-CD: n=22; poly(IC)-CD: n=20; poly(IC)-KD: n=21; *** p<0.001).
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WEIGHT
At 5 and 8 weeks of age, female mice were weighed. As expected, the saline-CD and
poly(IC)-CD groups gained significant weight during this 3 week time span. The poly(IC)KD females, however, did not significantly differ in weight between 3 weeks and 5 weeks of
age. Additionally, they weighed significantly less than the CD groups (Fig. 4)
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Figure 4. KD decreased weight gain. This figure weights at 3 weeks and 5 weeks of age for female mice in
each treatment-diet condition. Saline-CD and poly(IC)-CD mice weighed significantly more at 8 weeks of age
than at 5 weeks of age, while poly(IC)-CD mice did not differ in weight significantly between the two ages.
Poly(IC)-CD mice weighed significantly less at 8 weeks of age than saline-CD and poly(IC)-CD mice. (salineCD: n=13; poly(IC)-CD: n=9; poly(IC)-KD: n=11; *** p<0.001 between groups, ### p<0.001 within group).
Data were lost for the poly(IC)-CD male group, so male weight data is not presented.

24

SOCIABILITY MEASURES
SIDE CHAMBER TIMES
Side chamber times in the 3-chamber test were used to assess sociability. Poly(IC)KD males spent significantly more time in the target chamber during phase 2 as compared
both with their phase 1 scores and with the phase 2 times of both other groups. This
demonstrates that poly(IC)-KD males had a preference for sociability while poly(IC)-CD
and saline-CD males did not. No differences were found between the groups in the social
novelty phase 3 (Fig. 5A). For females, however, no differences were found between the
different groups. Each group showed significant preference for sociability in phase 2 and
no preference for social novelty in phase 3 (Fig. 5B).
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Figure 5. KD increases male poly(IC) sociability during 3-chamber test. (A) shows time spent by male
mice in the target chamber, which contained a stranger mouse (phase 2) or novel stranger mouse (phase 3),
as a percentage of total time spent in side chambers. Male poly(IC)-KD mice spent significantly more time in
the target chamber during phase 2 than during phase 1 and were significantly more social in phase 2 than
both other groups. (males: saline-CD, n=7; poly(IC)-CD, n=8; poly(IC)-KD, n=8; ** p<0.01 between groups, ##
p<0.01 within group). (B) shows time spent by female mice in the target chamber during the three-chamber
test. No significant differences existed between groups. Each group spent significantly more time in the target
chamber during phase 2 than in either phase 1 or 3. (females: saline-CD, n=12; poly(IC)-CD, n=12; poly(IC)KD, n=11; ### p<0.001 within group).
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SOCIAL CONTACT
Social contact made with the stranger mouse during the 3-chamber test was also
used to assess sociability. Social contact data yielded different results than data of side
chamber times. There were no significant differences between the sexes, so data were
collapsed. Time spent by the test mouse making social contact with the target mouse was
compared in phase 2 and phase 3. Poly(IC)-KD mice made significantly more social contact
than either saline-CD or poly(IC)-CD mice. Similar to 3-chamber data, social contact made
by saline- and poly(IC)-CD mice did not differ, demonstrating no deficit in either sociability
measure for poly(IC) mice (Fig. 6).
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Figure 6. KD increases social contact made by poly(IC) mice in 3-chamber test. Figure shows poly(IC)KD mice spent significantly more time making social contact with the target mouse's cage in phase 2 and 3
than the other treatment-diet groups. (saline-CD, n=19; poly(IC)-CD, n=18; poly(IC)-KD, n=21; ***p<0.001).
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REPETITIVE & COMPULSIVE BEHAVIOR MEASURES
THREE-CHAMBER TEST GROOMING
Time spent self-grooming during phase 1 and 2 of the 3-chamber test was measured
to assess self-directed repetitive behavior in a non-social and social setting. A treatment by
sex interaction was found. Male saline-CD and poly(IC)-CD mice groomed significantly
more in phase 2, the social phase, than in phase 1. Male poly(IC)-KD mice groomed
significantly less in the social phase than saline-CD and poly(IC)-CD mice. Additionally, time
spent grooming did not differ significantly between the social phase than the non-social
phase (Fig. 7A). Each female group groomed significantly more in phase 2 than phase 1,
although saline-CD mice showed the most distinct difference. In phase 2 female saline-CD
mice groomed significantly more than poly(IC)-CD and poly(IC)-KD (Fig. 7B).
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Figure 7. KD lowered
in poly(IC)
males in the social phasePhase
of Three-Chamber
Test (A) shows

time spent self-grooming by male mice during the 1st and 2nd phase of the three-chamber sociability test.
Grooming differed significantly between phase 1 and 2 for saline-CD and poly(IC)-CD mice, but not poly(IC)KD mice. In phase 2 male poly(IC)-KD mice groomed significantly less than the other treatment-diet groups.
(males: saline-CD, n=7; poly(IC)-CD, n=8; poly(IC)-KD, n=10; ### p<0.001 within group, *** <0.001 between
groups). (B) shows time spent self-grooming by female mice during the 1st and 2nd phase of the threechamber test. Grooming differed significantly between phase 1 and 2 for each treatment-diet group. Female
saline-CD mice groomed significantly more than the other groups in phase 2. (females: saline-CD, n=11;
poly(IC)-CD, n=12; poly(IC)-KD, n=11; ### p<0.001 within group, # p<0.05).
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SINGLE-CHAMBER GROOMING
Single-chamber grooming was also measured to assess self-directed repetitive
behaviors. Self-grooming while in a single-chamber was significantly higher for poly(IC)-CD
mice compared to the saline and KD groups. Grooming time of the poly(IC)-KD mice did not
significantly differ from grooming time of the saline-CD mice. Grooming was significantly
increased in offspring by poly(IC) MIA. KD returned grooming to normal levels (Fig. 8). This
supports a reversal of a poly(IC)-induced increase of self-grooming by KD.
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Figure 8. KD reverses increased self-grooming in poly(IC) mice. Figure shows the total time spent selfgrooming by the test mouse while in a single chamber. Self-grooming while in a single-chamber was
significantly higher for poly(IC)-CD mice compared to the saline and KD groups. Grooming time of the
poly(IC)-KD mice did not significantly differ from grooming time of the saline-CD mice. (saline-CD, n=19;
poly(IC)-CD, n=20; poly(IC)-KD, n=21; * p<0.05).
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MARBLE-BURYING
The extent of marble-burying performed by mice during a 30 minute phase was
used to assess compulsive behavior. There were no significant differences between any of
the groups (Fig. 9).
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Figure 9. No differences in marble burying between groups. The figure shows the amount of marble
pixels visible as a % of the total number of pixels of bedding. The baseline bar shows the amount of marble
visible in a test chamber before a mouse is introduced (n=10). No significant differences were found between
groups. (saline-CD, n=18; poly(IC)-CD, n=17; poly(IC)-KD, n=21).

SOCIAL COMMUNICATION MEASURES
STFP was conducted to investigate communication. To the best of the author's knowledge,
this measure has not been used on the poly(IC) mouse model before. Poly(IC)-CD mice ate
significantly more of the trained flavor (0.60±.10g) than the untrained flavor (0.11±.04g)
(n=12, p<0.01). Because no deficit was found in the poly(IC)-CD group, further analysis was
not conducted.
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DISCUSSION
POLY(IC) MOUSE MODEL OF AUTISM
In this study, blood, weight, and behavioral effects of KD on the poly(IC) mouse
model of autism were assessed. As a model for autism, poly(IC) has been previously shown
to exhibit core deficits of decreased social and communicative behavior as well as
increased repetitive and stereotyped behavior (Malkova et al., 2012). However, analysis of
our data showed an unexpected lack of abnormality in our poly(IC) for most behavioral
measures. Within the 3-chamber test paradigm, poly(IC) mice did not differ significantly
from saline controls for side preference times, social contact times, or grooming times.
Furthermore, marble-burying and STFP measures did not indicate a clear deficit for our
poly(IC) mice. At this time it is unclear if the lack of a difference between our poly(IC) and
saline controls stems from a failure to develop poly(IC) offspring with the full range of
autistic symptoms commonly attributed to them or if some abnormality was present in our
saline controls, inhibiting proper analysis of our poly(IC) mice.
SOCIABILITY
Several other studies have used the 3-chamber paradigm for sociability and have
found different results. A 2012 study by Malkova and colleagues found poly(IC) mice to be
significantly less social than their saline control counterparts (Malkova et al., 2012).
Similarly, Naviaux et al. (2013), in the process of investigating antipurinergic therapy for
autism features in the poly(IC) mouse, observed that poly(IC) mice were significantly less
social in the 3-chamber paradigm both by the side preference and social contact measures.
More recently, a study by Xuan & Hampson (2014) found that both males and female
subjects had reduced sociability in the 3-chamber test. Each of these studies focused their
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attention on the preference for sociability phase 2 portion of the 3-chamber test.
Interestingly, what makes our results markedly different from those of these studies is the
lack of a significant difference between the control and poly(IC) mice. Similar to other
studies, our male poly(IC) mice were considerably anti-social in the second phase of our 3chamber sociability test, spending only approximately 40% of their time in the chamber
with the stranger mouse. However, our saline controls also exhibited anti-social behavior,
prohibiting us from characterizing the anti-social behavior of our poly(IC) mice as
abnormal.
The difference between male and female mice within our 3-chamber paradigm is
not wholly unexpected as general literature is inconsistent regarding the severity of female
poly(IC) deficits. While it is unclear why female saline controls would be significantly social
in phase 2 while male saline mice were not, the lack of an anti-social characteristic in the
poly(IC) females is in agreement with the study by Naviaux and colleagues (2013) which
noted milder social abnormalities in their female poly(IC) mice. Other studies however
have seen decreased sociability for both males and females (Xuan & Hampson, 2014; Shi et
al., 2003; Schwartzer et al., 2013). Overall, there is a lack of research regarding female
poly(IC) mice.
Furthermore, the difference in results between the side preference and social
contact measures is of interest and requires explanation. Within the 3-chamber test, side
preference and social contact are both measures of sociability in the test mouse. Typically
the results of each of these measures are similar. Other studies have found that social
contact and chamber times are highly correlated; difference between them is mild or nonsignificant, and the main difference between the two measures is that social contact is a
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more sensitive measure of sociability (Silverman et al., 2012; Chadman, 2008; Nadler et al.,
2004). Therefore, the apparent difference between our chamber time and social contact
data with regard to our female mice (which exhibited very different group effects in the 3chamber test but were collapsed across sex in the social contact measure) was unexpected.
However, in our social contact data, there was a non-significant trend of sex effect (p=0.1)
with the female saline-CD and poly(IC)-CD groups grooming more than their male peers.
The difference of female data suggests that saline-CD and poly(IC)-CD mice spent
significant time in the side chamber without making significant contact with the stranger
mouse.
REPETITIVE BEHAVIORS
The measured levels of repetitive, stereotypical behaviors in our poly(IC) mice were
inconsistent. The lack of deficit in the marble-burying protocol is also unexpected. The
study by Malkova et al. found significantly increased marble burying in their male poly(IC)
mice (2012). Xuan & Hampson found similar results for their male (but not female) mice,
while Schwartzer et al. observed increased marble burying for both sexes (2014; 2013).
Increased grooming in the single-chamber paradigm of our study showed a marked
abnormality for poly(IC) mice. They groomed significantly more than saline controls,
indicating an autistic-like increase in self-directed repetitive behavior. Malkova et al. found
similar results while Xuan & Hampson did not detect a deficit in this measure. Grooming
behavior in the 3-chamber paradigm adds further question to the autistic phenotype of our
poly(IC) mouse model. Grooming times of poly(IC) mice in the first and second phase of the
3-chamber paradigm is thus far poorly researched. Our data revealed significantly
increased grooming in the social situation phase 2 for both saline and poly(IC) mice
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compared to non-social situation phase 1. In female mice, the increase in grooming was far
more pronounced in saline mice, which groomed significantly more than poly(IC) females
in phase 2. Therefore, our data did not indicate that the poly(IC) had increased self-directed
behavior in the social setting.
The difference seen in data between grooming in the 3-chamber test and in a singlechamber test may require further explanation. While both the phase 1 grooming and the
single chamber grooming were examples of grooming time in a non-social setting, data did
not look the same between the two measures. It should be noted that in the 3-chamber
protocol, phase 1 grooming is measured during the first 10 minutes that the mouse has
gained access to all three chambers of the apparatus. It is hypothesized that the resulting
exploratory behavior diminishes grooming that is otherwise observed in the single
chamber protocol (an environment to which the mouse has already been habituated 10
minutes prior to timing of stereotypy). Having already exhausted exploration during
habituation, greater grooming levels are seen in the single chamber protocol allowing for
differences to be detected.
Phase 2 grooming data provides different information than that given by the single
chamber protocol because grooming during phase 2 of the 3-chamber test, the social
setting, is often interpreted as an indicator of social anxiety. That is, a mouse is considered
socially anxious if it grooms more during the social phase (Mines et al., 2010; McNaughton
et al., 2008). Xuan & Hampson likewise found that while there was a trend towards
increased grooming, neither male nor female poly(IC) mice groomed significantly more in
the social phase of the 3-chamber test than saline controls (2014). While other literature
regarding this particular behavioral measure could not be found, these two studies in
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conjunction suggest that the poly(IC) mouse model may not exhibit an abnormality in this
measure of social condition grooming.
SOCIAL COMMUNICATION
In this study, social communication was tested using the social transmission of food
preference task. Our results indicated that poly(IC) mice performed this task without
deficit. To the author's knowledge this measure has not been used to study poly(IC) mice
with the exception of a pilot study which discovered a similar lack of deficit (Murphy,
2014). This information contributes to the growing body of knowledge surrounding the
behavioral phenotype of the poly(IC) mouse model of autism. Other studies that have
assessed communication have looked at vocalizations. Schwartzer et al. found no
abnormalities in the poly(IC) mice (2013). However, Malkova et al. (2012) found that
poly(IC) pups, compared to controls, emit fewer ultrasonic vocalizations in response to a
separation from their mother. Furthermore, the vocalizations are abnormal. In adults,
Malkova et al. saw a communication deficit in male poly(IC) scent-marking in response to
female urine.

EFFECTS OF THE KETOGENIC DIET ON THE POLY(IC) MOUSE
BLOOD AND WEIGHT
Our study found significant impacts of KD on blood and weight measurements. As
expected, three weeks on the 6.6:1 (carbohydrates: (fats+proteins)) strict KD resulted in
significantly increased ketone levels and significantly decreased glucose levels.
Furthermore, poly(IC) mice on the KD did not gain weight between 5 and 8 weeks of age
and weighed significantly less than the control diet groups at 8 weeks of age. This is
indicative of caloric or protein restriction for the KD group. The significant difference of
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blood ketone levels seen between males and females is not unexpected, as higher ketone
levels in females have been well documented (Deuel et al., 1937). The reason for the
significant difference in ketone levels of male and female poly(IC) mice on the control diet
is unclear. However, ketone levels are overall quite low in this treatment-diet group, so the
difference is of uncertain biological importance.
BEHAVIOR
Despite the unexpected results regarding our poly(IC) mice, significant and notable
effects of KD on the poly(IC) were observed. In males, the poly(IC)-KD group was
significantly more social in the 3-chamber test, and for both sexes, sociability in the form of
social contact was significantly increased. Grooming in the social phase 2 of the 3-chamber
test was significantly lower than both other groups for the male poly(IC) mice and
significantly lower than the saline group for female poly(IC) mice. Despite the sex
difference, KD mice had lower grooming times overall in this measure. KD reversed
poly(IC)-elevated grooming in the single chamber test. A diet effect was not seen in the
marble burying task. The sex differences seen in the 3-chamber sociability and grooming
may be a result of a less pronounced deficit in the poly(IC) mice as discussed above.
Overall, KD increased sociability and decreased grooming time, behavioral effects
considered beneficial in light of the core symptoms of ASD. These results are in agreement
with previous findings that have demonstrated that KD alleviates social deficits and
increased stereotyped behaviors in mouse models of autism. Ruskin et al. (2013) found
that a strict KD reduced grooming in the single chamber and 3-chamber test and increased
preference for sociability and social contact in the 3-chamber test for the BTBR mouse
model of autism. Another study investigating the effect of KD on EL mice, a mouse model of
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epilepsy and autism, found that strict KD improved autistic symptoms for female EL mice,
decreasing self-directed repetitive behavior and increasing sociability within the 3chamber test (Fortin, 2014). The EL and BTBR mice are genetic in etiology while the
poly(IC) is environmental. Together, these results indicate that KD may be a promising diet
therapy for autism, both genetic and environmental in etiology.
The mechanisms by which KD may be beneficial are relatively unknown. However, it
is suggested that saturated fatty acids, the levels of which are raised by the diet, activate
toll-like receptors contribute to an anti-inflammatory effect (Forsythe et al., 2008). KD also
fundamentally alters metabolism which is often abnormal in autistic patients (Chauan et al.,
2011). Furthermore, KD increases adenosine in the brain. The promotion and reduction of
adenosine's function is associated with the alleviation and promotion several symptoms
and comorbidities of autism, respectively (Masino et al., 2009; Masino et al., 2011; Poon &
Sawynok, 1999; Freitag et al., 2009; Bottini et al., 2001). Further research is needed to fully
explore the mechanisms and applications of KD.
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CONCLUSIONS AND FUTURE DIRECTIONS
This study demonstrated a clear influence of strict KD on behavior in the poly(IC)
mice towards the improvement of sociability and alleviation of self-directed stereotyped
behavior. While our study did not succeed in replicating several autistic behaviors in the
poly(IC) mouse model, these effects of KD suggest that KD may be an effective diet therapy
for autism and indicate a strong need for further research.
In the future, research regarding the effect of KD on the autistic symptoms of the
poly(IC) mouse model may use altered methods to elicit a clear deficit in the poly(IC) mice
and ensure a lack of abnormality in the control group. Strategies towards this goal may
include utilizing pups from an un-injected dam for further controls. A single injection
procedure rather than the three injection procedure used here may reduce maternal stress
caused by repeated handling. To assess the degree of immune response from both saline
and poly(IC) injected dams, inflammation markers indicative of immune response may be
monitored. Additionally, the injection of interleukin-6 (IL6) instead of poly(IC) may be
considered. This pro-inflammatory cytokine is a critical mediator of the effect of poly(IC)
(Smith et al., 2007). Direct injection of IL6 may reduce variability of behavior in offspring.
Furthermore, while the sex differences seen in our data is not wholly unexpected and a
group effect of estrus cycle should have been eliminated through the random testing of our
procedure, monitoring estrus cycle in our female test mice may be illuminating.
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